NCT06970379

Brief Summary

Different types of grafting substances have been used in the recent decade to accelerate bone healing at large bony facial defects. PRF was one of the gold standard materials to be used until it was replaced by its successor T-PRF due to the PRF hazards of preparation. However, T-PRF- still can't stand alone in full bone enhancement procedure. Therefore, the combination with another bone bio-modulation technique, like Low-level Laser Therapy, is a must to approach the full advantage of bone healing. Aim: To compare between the effect of using T-PRF versus T-PRF with Low Level Laser stimulation on bone healing at posterior mandibular fractures

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

10 months

First QC Date

May 13, 2025

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in bone density

    immediate postoperative CT-scan will be performed and compared with another CT-scan done 12 weeks (3 months) later. The on-demand software (OnDemand 3D APP-DBM, Cybermed, Seoul, South Korea) will be used to calculate bone mineral density in Hounsfield Units (HU). Six measurements will be taken along the fracture line, and the mean will be measured for each patient.

    Baseline and 3 months

  • Change in mouth opening

    With the help of a millimeter ruler, the maximal inter-incisal distance is going to be assessed

    baseline, 24 hrs, 1 week, 4 weeks, 6 weeks, 12 weeks

  • Change in wound healing

    Early Wound Healing Score (EHS) the following will be assessed and each will be scored from 0 to 2 1. Clinical signs of re-epithelization (CSR) 2. Clinical signs of haemostasias (CSH) 3. Clinical signs of inflammation (CSI)

    baseline, 24 hrs, 1 week, 4 weeks, 6 weeks, 12 weeks

Secondary Outcomes (2)

  • change in pain scores

    24 hrs, 1 week, 4 weeks

  • change in edema

    baseline, 24 hrs, 1 week, 4 weeks, 6 weeks, 12 weeks

Study Arms (2)

T-PRF

EXPERIMENTAL
Other: T-PRF

T-PRF and LLLT

EXPERIMENTAL
Other: T-PRF and Laser biomodulation

Interventions

T-PRFOTHER

Patients received T-PRF placement at the fracture line.

T-PRF

Subjects underwent the process of bio-stimulation of the fracture line using low-level laser therapy. Wavelength \[λ\]: 660 nm, Power: 100 mW, Spot size \[Ø\]: 0.06 cm2, and for 60 seconds

T-PRF and LLLT

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients suffering from posterior mandibular fracture

You may not qualify if:

  • Patients with an untreated old Mandibular fracture.
  • Patient with hematological diseases (thrombocytopenia, hemorrhagic disease, and diabetes).
  • Comminuted fracture with bone loss.
  • There is an infection at the fracture line.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt

Alexandria, Azarita, 00203, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2025

First Posted

May 14, 2025

Study Start

March 30, 2024

Primary Completion

January 21, 2025

Study Completion

January 21, 2025

Last Updated

May 14, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations